Comparing lower dose versus same dose antipsychotics for schizophrenia
Part of Mental health clinical trials.
This study tests whether gradually reducing the dose of antipsychotic medication is as safe and effective as staying on the current dose for people with stable schizophrenia spectrum disorder. It aims to personalize treatment to find the lowest effective dose for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old
- Have a diagnosis of schizophrenia, schizoaffective disorder, or a related condition
- Be on a stable oral antipsychotic medication for at least 6 months and have mild symptoms
- Have a caregiver who supports you and can be reached easily
- Not be currently hospitalized, in crisis, or at risk of harming yourself or others
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
This study looks at safely reducing or stopping antipsychotic medication in adults with psychotic disorders who are stable and interested in trying. It aims to understand how to best support patients during this process.
This trial is testing whether it is safe to slowly reduce or stop anticholinergic medications (benztropine or trihexyphenidyl) in people with schizophrenia. It aims to see if stopping these drugs can help with thinking and memory without causing worsening movement problems.
This trial looks at whether taking an antipsychotic every other day can keep symptoms controlled in adults with schizophrenia or another psychotic disorder. It may help some people avoid daily dosing, but it requires specific medication stability and screening checks.
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
This trial tests whether a more intensive medication approach for schizophrenia (or related conditions) helps people who didn’t improve on their first tried medicine. Participants will usually switch medicines and be compared against “treatment as usual.”
Hear when a new Schizophrenia Spectrum and Other Psychotic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.